December 10, 2018

MANF-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients:  Mesencephalic astrocyte-derived neurotrophic factor (MANF) increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes, via up-regulation of its target gene, 11/December/2018, 5.19 am

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was […]
December 10, 2018

 Erythropoietin (EPO)-based therapy for body weight control, energy homeostasis and TIIDM: Erythropoietin (EPO) decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up-regulation of its target gene, 11/December/2018, 5.00 am

Introduction: What they say  A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]